Skip to main content
Log in

Antibacterial Properties of Intestinal Phospholipase A2 from the Common Stingray Dasyatis pastinaca

  • Published:
Applied Biochemistry and Biotechnology Aims and scope Submit manuscript

Abstract

Stingray phospholipase A2 group IIA (SPLA2-IIA) was recently isolated and purified to homogeneity from the intestine of the common stingray Dasyatis pastinaca, suggesting that this enzyme plays an important role in systemic bactericidal defense. The present study showed that SPLA2-IIA was highly bactericidal against Gram-positive bacteria with inhibition zones and minimal inhibitory concentration values in the range of 13–25 mm and 2–8 μg/ml, respectively, whereas Gram-negative bacteria exhibited a much higher resistance. The bactericidal efficiency of SPLA2-IIA was shown to be unaffected by high protein and salt concentrations, but dependent upon the presence of calcium ions, and then correlated to the hydrolytic activity of membrane phospholipids. Importantly, we showed that stingray phospholipase A2 group IIA presents no cytotoxicity after its incubation with MDA-MB-231 cells. SPLA2-IIA may be considered as a future therapeutic agent against bacterial infections.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

SPLA2-IIA:

Stingray phospholipase A2 group IIA

sPLA2 :

Secreted phospholipase A2

SPLA2-IB:

Stingray phospholipase A2 group IB

References

  1. Kini, R. M. (1997). In R. M. Kini (Ed.), Venom phospholipase A2, enzyme: structure, function and mechanism (pp. 1–26). New York: Wiley.

    Google Scholar 

  2. Dennis, E. A., Cao, J., Hsu, Y. H., Magrioti, V., & Kokotos, G. (2011). Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Chemistry Review, 111, 6130–6185.

    Article  CAS  Google Scholar 

  3. Six, D. A., & Dennis, E. A. (2000). The expanding superfamily of phospholipase A2 enzymes: classification and characterization. Biochimica et Biophysica Acta, 1488, 1–19.

    Article  CAS  Google Scholar 

  4. Rintala, E. M., & Nevalainen, T. J. (1993). Group II phospholipase A2 in sera of febrile patients with microbiologically or clinically documented infections. Clinical Infectious Diseases, 252, 4913–4921.

    Google Scholar 

  5. Büchler, M., Malfertheiner, P., Schädlich, H., Nevalainen, T. J., Friess, H., & Beger, H. G. (1989). Role of phospholipase A2 in human acute pancreatitis. Gastroenterology, 97, 1521–1526.

    Google Scholar 

  6. Weiss, J., Inada, M., Elsbach, P., & Crowl, R. M. (1994). Structural determinants of the action against Escherichia coli of a human inflammatory fluid phospholipase A2 in concert with polymorphonuclear leukocytes. The Journal of Biological Chemistry, 269, 26331–7.

    CAS  Google Scholar 

  7. Weinrauch, Y., Elsbach, P., Madsen, L. M., Foreman, A., & Weiss, J. (1996). The potent anti Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2. The Journal of Clinical Investigation, 97, 250–257.

    Article  CAS  Google Scholar 

  8. Laine, V. J., Grass, D. S., & Nevalainen, T. J. (1999). Protection by group II phospholipase A2 against Staphylococcus aureus. Journal of Immunology, 162, 7402–7408.

    CAS  Google Scholar 

  9. Laine, V. J., Grass, D. S., & Nevalainen, T. J. (2000). Resistance of transgenic mice expressing human group II phospholipase A2 to Escherichia coli infection. Infection and Immunity, 68, 87–92.

    Article  CAS  Google Scholar 

  10. Grönroos, J. O., Laine, V. J., & Nevalainen, T. J. (2002). Bactericidal group IIA phospholipase A2 in serum of patients with bacterial infections. The Journal of Infectious Diseases, 185, 1767–1772.

    Article  Google Scholar 

  11. Nevalainen, T. J., Aho, H. J., & Peuravuori, H. (1994). Secretion of group 2 phospholipase A2 by lacrimal glands. Investigative Ophthalmology & Visual Science, 35, 417–421.

    CAS  Google Scholar 

  12. Qu, X. D., & Lehrer, R. I. (1998). Secretory phospholipase A2 is the principal bactericide for Staphylococci and other gram-positive bacteria in human tears. Infection and Immunity, 66, 2791–2797.

    CAS  Google Scholar 

  13. Madsen, L. M., Inada, M., & Weiss, J. (1996). Determinants of activation by complement of group II phospholipase A2 acting against Escherichia coli. Infection and Immunity, 64, 2425–2430.

    CAS  Google Scholar 

  14. Elsbach, P., Weiss, J., Franson, R. C., Beckerdite-Quangliata, S., Schneider, A., & Harris, L. (1979). Separation and purification of a potent bactericidal/ permeability-increasing protein and a closely associated phospholipase A2 from rabbit polymorphonuclear leukocytes: observations on their relationship. The Journal of Biological Chemistry, 254, 11000–11009.

    CAS  Google Scholar 

  15. Harwig, S. S. L., Tan, L., Qu, X. D., Cho, Y., Eisenhauer, B. P., & Lehrer, R. I. (1995). Bactericidal properties of murine intestinal phospholipase A2. The Journal of Clinical Investigation, 95, 603–610.

    Article  CAS  Google Scholar 

  16. Kobeghenova, S. S. (1992). Morphology and morphogenesis of the digestive system of some cartilaginous fishes (Chondrichthyes). Zoological Journal, 71, 108–122.

    Google Scholar 

  17. Koduri, R. S., Gronroos, J. O., Laine, V. J., Le Calvez, C., Lambeau, G., Nevalainen, T. J., et al. (2002). Bactericidal properties of human and murine groups I, II, V, X, and XII secreted phospholipases A(2). The Journal of Biological Chemistry, 277, 5849–5857.

    Article  CAS  Google Scholar 

  18. Karray, A., Ben Ali, Y., Gargouri, Y., & Bezzine, S. (2011). Antibacterial properties of chiken intestinal phospholipase A2. Lipids in Health and Disease, 10, 4–13.

    Article  CAS  Google Scholar 

  19. Karray, A., Frikha, F., Ben Ali, Y., Gargouri, Y., & Bezzine, S. (2011). Purification and biochemical characterization of a secreted group IIA chicken intestinal phospholipase A2. Lipids in Health and Disease, 10, 27–38.

    Article  CAS  Google Scholar 

  20. Ben Bacha, A., Karray, A., Bouchaala, E., Gargouri, Y., & Ben Ali, Y. (2011). Purification and biochemical characterization of pancreatic phospholipase A2 from the common stingray Dasyatis pastinaca. Lipids in Health and Disease, 10, 32–39.

    Article  CAS  Google Scholar 

  21. Bradford, M. M. (1976). A rapid and sensitive method for the quantification of microgram quantities of proteins utilizing the principle of protein-dye binding. Analytical Biochemistry, 72, 248–254.

    Article  CAS  Google Scholar 

  22. Buckland, A. G., & Wilton, D. C. (2000). The antibacterial properties of secreted phospholipases A(2). Biochimica et Biophysica Acta, 1488, 71–82.

    Article  CAS  Google Scholar 

  23. Grönroos, J. O., Salonen, J. H., Viander, M., Nevalainen, T. J., & Laine, V. J. O. (2005). Roles of group IIA phospholipase A2 and complement in killing of bacteria by acute phase serum. Journal of Immunology, 62, 413–419.

    Google Scholar 

  24. Beers, S. A., Buckland, A. G., Koduri, R. S., Cho, W., Gelb, M. H., & Wilton, D. C. (2002). The antibacterial properties of secreted phospholipases A2: a major physiological role for the group IIA enzyme that depends on the very high pI of the enzyme to allow penetration of the bacterial cell wall. The Journal of Biological Chemistry, 277, 1788–1793.

    Article  CAS  Google Scholar 

  25. Foreman-Wykert, A. K., Weinrauch, Y., Elsbach, P., & Weiss, J. (1999). Phospholipid synthesis by Staphylococcus aureus during (sub) lethal attack by mammalian 14-kilodalton group IIA phospholipase A2. The Journal of Clinical Investigation, 103, 715–721.

    Article  CAS  Google Scholar 

  26. Dubouix, A., Campanac, C., Fauvel, J., Simon, M. F., Salles, J. P., Roques, C., et al. (2003). Bactericidal properties of group IIa secreted phospholipase A(2) against Pseudomonas aeruginosa clinical isolate. Journal of Medical Microbiology, 52, 1039–1045.

    Article  CAS  Google Scholar 

  27. Foreman-Wykert, A. K., Weiss, J., & Elsbach, P. (2000). Phospholipid synthesis by Staphylococcus aureus during (sub) lethal attack by mammalian 14-kilodalton group IIA phospholipase A2. Infection and Immunity, 68, 1259–1264.

    Article  CAS  Google Scholar 

  28. Nyman, K. M., Häggblom, J. O., & Nevalainen, T. J. (1997). In W. Uhl, T. J. Nevalainen, & M. W. Büchler (Eds.), Toxic effects of phospholipase A2 in vitro, vol 24: Phospholipase A2. Basic and clinical aspects in inflammatory diseases (pp. 176–181). Karger: Prog. Surg. Basel.

    Google Scholar 

  29. Vadas, P., & Pruzanski, W. (1997). In W. Uhl, T. J. Nevalainen, & M. W. Büchler (Eds.), Inter-relationship of phospholipase A2 and lipid peroxidation in multisystem organ failure in septic shock. vol 24: Phospholipase A2. Basic and clinical aspects in inflammatory diseases (pp. 176–181). Karger: Prog. Surg. Basel.

    Google Scholar 

  30. Grönroos, J. O., Veli, J., Laine, O., Marcel, J., Janssen, W., Egmond, M. R., et al. (2001). Bactericidal Properties of Group IIA and Group V Phospholipases A2. Journal of Immunology, 166, 4029–4034.

    Google Scholar 

  31. Sapirstein, A., Spech, R. A., Witzgall, R., & Bonventre, J. V. (1996). Cytosolic phospholipase A2 (PLA2), but not secretory PLA2, potentiates hydrogen peroxide cytotoxicity in kidney epithelial cells. The Journal of Biological Chemistry, 271, 21505–21513.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The authors extend their appreciation to the Deanship of Scientific Research at King Saud University for funding the work through the research group project no: RGP-VPP-070.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Abir Ben Bacha.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ben Bacha, A., Abid, I. & Horchani, H. Antibacterial Properties of Intestinal Phospholipase A2 from the Common Stingray Dasyatis pastinaca . Appl Biochem Biotechnol 168, 1277–1287 (2012). https://doi.org/10.1007/s12010-012-9856-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12010-012-9856-8

Keywords

Navigation